File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks

TitleMisoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks
Authors
KeywordsMisoprostol
Second trimester
Termination of pregnancy
Issue Date2007
PublisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ijgo
Citation
International Journal Of Gynecology And Obstetrics, 2007, v. 99 SUPPL. 2, p. S178-S181 How to Cite?
AbstractA combination of mifepristone and misoprostol is the regimen of choice for termination of pregnancy between 13 to 26 weeks. In many countries, mifepristone is still not available, and misoprostol has to be used alone. Many misoprostol-alone regimens have been reported in the literature with apparently good results. Most of the trials were conducted in pregnancies between 13 and 22 weeks. For this gestational period, we recommend the regimen of 400 μg of vaginal misoprostol every 3 h up to 5 doses, as it appears to be effective without excessive side effects or complications. There is inadequate data to recommend a regimen for the gestational period of 23 to 26 weeks but it is advisable to reduce the dose and frequency of administration of misoprostol. Common side effects of misoprostol-induced termination of pregnancy include gastrointestinal side effects, abdominal cramps, bleeding, fever and chills. Complications may include infection or rarely rupture of uterus. © 2007 International Federation Of Gynecology and Obstetrics.
Persistent Identifierhttp://hdl.handle.net/10722/87156
ISSN
2015 Impact Factor: 1.674
2015 SCImago Journal Rankings: 1.544
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorHo, PCen_HK
dc.contributor.authorBlumenthal, PDen_HK
dc.contributor.authorGemzellDanielsson, Ken_HK
dc.contributor.authorGómez Ponce de León, Ren_HK
dc.contributor.authorMittal, Sen_HK
dc.contributor.authorTang, OSen_HK
dc.date.accessioned2010-09-06T09:26:03Z-
dc.date.available2010-09-06T09:26:03Z-
dc.date.issued2007en_HK
dc.identifier.citationInternational Journal Of Gynecology And Obstetrics, 2007, v. 99 SUPPL. 2, p. S178-S181en_HK
dc.identifier.issn0020-7292en_HK
dc.identifier.urihttp://hdl.handle.net/10722/87156-
dc.description.abstractA combination of mifepristone and misoprostol is the regimen of choice for termination of pregnancy between 13 to 26 weeks. In many countries, mifepristone is still not available, and misoprostol has to be used alone. Many misoprostol-alone regimens have been reported in the literature with apparently good results. Most of the trials were conducted in pregnancies between 13 and 22 weeks. For this gestational period, we recommend the regimen of 400 μg of vaginal misoprostol every 3 h up to 5 doses, as it appears to be effective without excessive side effects or complications. There is inadequate data to recommend a regimen for the gestational period of 23 to 26 weeks but it is advisable to reduce the dose and frequency of administration of misoprostol. Common side effects of misoprostol-induced termination of pregnancy include gastrointestinal side effects, abdominal cramps, bleeding, fever and chills. Complications may include infection or rarely rupture of uterus. © 2007 International Federation Of Gynecology and Obstetrics.en_HK
dc.languageengen_HK
dc.publisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/ijgoen_HK
dc.relation.ispartofInternational Journal of Gynecology and Obstetricsen_HK
dc.rightsInternational Journal of Gynecology & Obstetrics. Copyright © Elsevier Ireland Ltd.en_HK
dc.subjectMisoprostolen_HK
dc.subjectSecond trimesteren_HK
dc.subjectTermination of pregnancyen_HK
dc.titleMisoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeksen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0020-7292&volume=99 &issue=Supplement 2&spage=S178&epage=S181&date=2007&atitle=Misoprostol+for+the+termination+of+pregnancy+with+a+live+fetus+at+13+to+26+weeksen_HK
dc.identifier.emailHo, PC:pcho@hku.hken_HK
dc.identifier.authorityHo, PC=rp00325en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.ijgo.2007.09.007en_HK
dc.identifier.pmid17961566-
dc.identifier.scopuseid_2-s2.0-36048977591en_HK
dc.identifier.hkuros146630en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-36048977591&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume99en_HK
dc.identifier.issueSUPPL. 2en_HK
dc.identifier.spageS178en_HK
dc.identifier.epageS181en_HK
dc.identifier.isiWOS:000251803100006-
dc.publisher.placeIrelanden_HK
dc.identifier.scopusauthoridHo, PC=7402211440en_HK
dc.identifier.scopusauthoridBlumenthal, PD=7004570773en_HK
dc.identifier.scopusauthoridGemzellDanielsson, K=7003551602en_HK
dc.identifier.scopusauthoridGómez Ponce de León, R=24821132100en_HK
dc.identifier.scopusauthoridMittal, S=16444643600en_HK
dc.identifier.scopusauthoridTang, OS=7006723402en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats